KRAS and acute myeloid leukemia: Among non‐11q23/KMT2A‐rearranged AML, the recurrent gene mutations were NRAS (n = 105, 37.9%), KIT (n = 72, 26.0%), FLT3‐ITD (n = 47, 17.0%), WT1 (n = 36, 13.0%), and KRAS (n = 28, 10.1%).